Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I see this so often on these boards. What does it matter to you? If someone has bought at 20p, 30p, 40p, etc. then it was their choice. (though I hope they weren't swayed by ramping) The share price has declined. Many posters have touted a trading range of 19p to 22p in the last few months. Ridiculous. It is what it is. No data, delay, no communication equals no SP rise, only fall. It's nothing to do with Ukraine. It's nothing to do with "shares being tightly held". It's nothing to do with "pivotal year". Nothing to do with "tick-tock". You either understand the risks involved or you don't. This is a high risk share. Never risk what you can't afford to lose. Personally, I'm in for the long term but I'm acutely aware that some may be swayed by the "happy clappers" who post on this BB. Too everyone, be careful...
“We've launched a $200million call to fund vaccines that are broadly protective against SARS-CoV-2 variants and other coronaviruses.
The first partnerships to be made through this Call will be announced in the coming weeks”
https://twitter.com/cepivaccines/status/1446494407830741014?s=21
You never know…..
Apologies if already posted
https://cepi.net/news_cepi/clover-biopharmaceuticals-announces-positive-efficacy-data-from-phase-2-3-trial/
https://www.investegate.co.uk/scancell-hlds/rns/pdmr-dealing/202109091631543227L/
OK, chelsea7, I apologise for my mix-up
The 7-10 day response time was posted by Chelsea7 so best to ask him about the foundation of the statement
Usually, I have no interest in the day to day fraction-of-a-penny price movements of this share. It’s been meaningless over the last 10 + years . However, analysing the last few days trades shows that sellers have been unscrupulously milked for the benefit of buyers. I sense that the planets are aligning and it will, finally, come good. Exciting times in an uncertain and gloomy world. Keep the faith.
From 15:03 pm !
For 226,230 shares at 14.55 pence from 14:55pm
Scancell get a one-word mention and the whole article gives a good overview of companies developing a vaccine.
https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
Chelsea7, you seem to be stirring it a bit. You have to remember that this is a public forum that is open to all. Any one can post their views (as long as they adhere to LSE’s rules) and if you don’t like it then that’s tough. You are not the site administrator or the sheriff of this SCLP board. I’ve been reading this board before you decided to join and, from what I gather, you don’t understand the science (by your own admittance), I don’t think you understand the bio-pharma industry enough and you have spent a huge amount of money buying shares that could have been bought at a much lower cost had you been patient. You need to detach yourself emotionally from this share and stop jumping down other people's throats.